The Chemistry, Manufacturing and Controls Strategy Meeting – East Coast USA 2026 brings together senior CMC leaders from pharmaceutical and biotechnology companies to discuss the most pressing challenges in drug development, manufacturing scale-up, regulatory compliance, and emerging therapeutic modalities.
Biomanufacturing innovation and scaling biologics production
Technology transfer and analytical development strategies
Outsourcing and process research & scale-up
Integrated drug development and digital transformation in CMC
Emerging modalities such as cell, gene, and oligonucleotide therapies
Unlike traditional conferences, this strategy meeting is built around interactive roundtables, curated networking sessions, and pre-qualified 1-to-1 meetings, enabling sponsors to engage directly with decision-makers responsible for CMC strategy, manufacturing operations, regulatory submissions, and development pipelines.
Sponsors gain the opportunity to position their solutions in front of senior leaders actively evaluating partners and technologies, making this event a highly efficient platform for lead generation and relationship building.
The meeting focuses on the most important topics shaping the CMC landscape today, including:
Drug substance, drug product, and drug delivery innovation
Through expert-led discussions and structured networking, sponsors can build meaningful connections with organizations seeking partners to accelerate drug development and commercialization.
Chief Technical Officers (CTO)
Vice Presidents of CMC
Heads of Process Development
Directors of Analytical Development
Heads of Manufacturing and Technical Operations
Regulatory Affairs CMC Leaders
Heads of Drug Product & Drug Substance Development
Bioprocess and Biomanufacturing Leaders
Clinical Supply and Technology Transfer Directors
The Chemistry, Manufacturing and Controls Strategy Meeting is designed to maximize meaningful interactions between sponsors and pharma decision-makers.
Biomanufacturing
Technology Transfer & Analytical
Outsourcing / Process Research & Scale-up
Integrated Drug Development
Emerging / New Modalities
Drug Substance, Drug Product, Drug Delivery
Throughout the event, participants will engage with:
Private Equity & Venture Capital
Hosting the meeting in Boston places sponsors at the heart of one of the world’s most concentrated life sciences ecosystems.
Boston’s dynamic life sciences cluster fosters collaboration between industry, academia, and investors—making it an ideal environment for meaningful discussions around CMC strategy, manufacturing innovation, and drug development advancement.
Leading pharmaceutical and biotechnology headquarters
World-renowned academic institutions and research hospitals
Emerging biotech startups driving next-generation therapeutics
The Boston–Cambridge region is internationally recognized as a global hub for biotechnology, pharmaceutical innovation, and academic research, making it the ideal location for a CMC strategy meeting.
The region offers proximity to:
Venture capital firms supporting life sciences innovation
A dense network of CDMOs, CROs, and technology providers
Keynote Presentation
Roundtable Discussion Leadership
Pre-Qualified One-to-One Meetings
Branding, Visibility & Exhibition Opportunities
Sponsorship packages are designed to help organizations maximize brand visibility and generate high-quality business opportunities.
Each package can be customized to align with your marketing objectives and business development goals.
Proventa International’s strategy meetings have helped numerous solution providers build relationships with leading pharmaceutical and biotechnology organizations.
Sponsors consistently highlight the value of the intimate event format and targeted audience, which enable productive discussions and genuine collaboration.
Detailed sponsorship packages
Delegate insights and attendee profiles
Available presentation and roundtable opportunities
Custom partnership options tailored to your objectives
